MGC Pharma (ASX:MXC) passes 2000 prescribed units
- MGC Pharmaceuticals (MXC) has passed 2000 prescribed units of its cannabinoid medicines
- The increased prescriptions come from patients in Australia and the U.K. as well as Brazil and Ireland where the products were recently approved for sale
- These prescriptions are for MGC Pharma's CannEpil and its high CBD medicine MXP100
Reaches 2000 prescribed units
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.020(4.71%) |
Mkt cap ! $18.33M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 42.5¢ | 40.5¢ | $2.738K | 6.603K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9016 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 44113 | 1 |
View Market Depth
| Last trade - 11.36am 25/04/2024 (20 minute delay) ? |
| RGT (ASX) Chart |